The art of prescribing. Depression and fibromyalgia syndrome (FMS): pharmacologic considerations.
Antai-Otong
Deborah
D
deborah.antai-otong@med.va.gov
D000928:Antidepressive Agents / Q000627:therapeutic use*; D002908:Chronic Disease; D015928:Cognitive Behavioral Therapy; D003863:Depression / Q000175:diagnosis / Q000188:drug therapy*; D011307:Drug Prescriptions; D005081:Exercise Therapy; D005356:Fibromyalgia / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D018579:Patient Selection; D000069583:Pregabalin; D017009:Professional Autonomy; D011568:Psychiatric Nursing / Q000458:organization & administration; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D005680:gamma-Aminobutyric Acid / Q000031:analogs & derivatives / Q000627:therapeutic use
D000928:Antidepressive Agents; D000069583:Pregabalin; D017367:Selective Serotonin Reuptake Inhibitors; D005680:gamma-Aminobutyric Acid